RecruitingPhase 3NCT06841354A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Sponsor: Merck Sharp & Dohme LLCSalt Lake City, UT · +38 more sites
RecruitingPhase 2NCT06680830A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseaseSponsor: Neuron23 Inc.Salt Lake City, UT · +44 more sites
RecruitingNot applicableNCT07705373A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson DiseaseSponsor: Boston University Charles River CampusSalt Lake City, UT · +2 more sites
RecruitingPhase not listedNCT04071847Abbott DBS Post-Market Study of Outcomes for Indications Over TimeSponsor: Abbott Medical DevicesSalt Lake City, UT · +22 more sites
Not yet recruitingPhase 4NCT07187466Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson DiseaseSponsor: VA Office of Research and DevelopmentSalt Lake City, UT · +2 more sites